Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eterna Therapeutics Inc. | Former director | Warrants (right to buy) | 83.9K | Jul 13, 2023 | Direct | ||
Eterna Therapeutics Inc. | Former director | 6.0% Senior Convertible Promissory Notes due 2028 | $120K | Jul 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ERNA | Eterna Therapeutics Inc. | Aug 8, 2023 | 0 | $0 | 4 | Aug 10, 2023 | Former director |
ERNA | Eterna Therapeutics Inc. | Jul 14, 2023 | 2 | $130K | 4 | Jul 18, 2023 | Director |
ERNA | Eterna Therapeutics Inc. | Jul 6, 2023 | 0 | $0 | 3 | Jul 11, 2023 | Director |